KLOW and GLOW blends — what is in each and how they differ
KLOW is GHK-Cu, BPC-157, TB-500 and KPV. GLOW is the same minus KPV. What the fourth component changes and how the totals divide.
KLOW and GLOW are four- and three-component blends built on the same core. KLOW contains GHK-Cu, BPC-157, TB-500 and KPV at 80 mg total. GLOW contains GHK-Cu, TB-500 and BPC-157 at 70 mg total. The difference between them is KPV, a tripeptide the three-component version leaves out.
By the Bench Grade Research Team ·
The two formulations side by side
| KLOW 80 mg | GLOW 70 mg | |
|---|---|---|
| GHK-Cu | yes | yes |
| BPC-157 | yes | yes |
| TB-500 | yes | yes |
| KPV | yes | no |
| Components | 4 | 3 |
The names are acronyms of their components rather than descriptions of anything: K-L-O-W and G-L-O-W. Like all blend names they identify a product, not a substance, and neither has a CAS number or a molecular weight of its own.
What the fourth component is
KPV is a tripeptide — lysine, proline, valine — corresponding to residues 11 to 13 of alpha-MSH. At 342.43 g/mol it is the smallest component in either blend by a wide margin, which has a practical consequence: a given milligram mass of KPV is far more molecules than the same mass of TB-500 at 4963 g/mol.
This is the general rule with blends and it is easy to miss. Equal masses of different peptides are very unequal molar amounts, so the mass split across components tells you less about the mixture than it appears to.
How the total mass divides
An 80 mg four-component blend and a 70 mg three-component blend are not straightforwardly comparable. The headline number is total peptide across all components, so more components divided into a similar total means less of each. Comparing them requires the per-component split, which is the number worth asking for.
What each of the four components is studied for
| Component | In GLOW | In KLOW | Molecular function described in the literature |
|---|---|---|---|
| GHK-Cu | yes | yes | Copper(II) complex; copper is a required cofactor for lysyl oxidase, which cross-links collagen and elastin |
| BPC-157 | yes | yes | Angiogenic and nitric-oxide pathway effects proposed from rodent tissue models |
| TB-500 | yes | yes | Binds monomeric G-actin, regulating the pool available for filament assembly |
| KPV | no | yes | C-terminal tripeptide of alpha-MSH; cell-culture work describes effects on inflammatory signalling |
The three shared components are not three versions of one idea. Copper delivery to an enzyme system, a proposed vascular effect, and regulation of the cytoskeletal protein pool are three different kinds of claim resting on three different qualities of evidence.
What adding KPV changes
KPV is the only structural difference between the two blends, and it is the smallest component in either by a wide margin — 342.43 g/mol against 4963.44 for TB-500, a factor of nearly thirteen.
That size difference is not cosmetic. At a given milligram mass, KPV contributes roughly thirteen times as many molecules as TB-500 does, so a mass split that looks balanced on the label is heavily weighted toward the small component in molar terms. Anyone comparing these two blends on total milligrams is comparing the wrong number.
The published work on this tripeptide describes activity that does not require the melanocortin receptors its parent hormone acts at, which is the reason it is studied as a fragment rather than treated as a stand-in for alpha-MSH.
Why copper is in both, and what it costs
GHK-Cu appears in both blends because copper is a required cofactor for lysyl oxidase — the enzyme, characterised in the biochemical literature, that forms the cross-links giving collagen and elastin their mechanical properties. The dermatological literature examines the complex on that basis — the proposed mechanism is metal delivery to an enzyme system rather than a peptide binding a receptor.
It carries a handling cost that applies to the whole vial. Copper complexes are more light-sensitive than plain peptides, and copper ions catalyse oxidation of other species. Both blends also contain TB-500, which carries an oxidation-prone methionine, so the copper and the most fragile component share a container. The vial must be stored to the standard of whichever component is least tolerant.
Three or four sets of uncertainty
The evidence behind these components differs in kind. Copper's role as a lysyl oxidase cofactor is established biochemistry. Thymosin beta-4's actin sequestration is established cell biology. BPC-157's mechanism is proposed and inferred from rodent outcomes. KPV's is described from cell-culture work.
A three-component blend inherits three of those positions plus three pairwise interactions nobody has studied; a four-component blend inherits four plus six. Neither blend has been studied as a blend. That accounting is the honest one and it is the opposite of how multi-component products are usually sold.
Verification for a multi-component vial
- Purity should be reported per component. A single area-percent figure for a mixture does not describe any of the peptides in it.
- Mass spectrometry should confirm each component's molecular weight, four confirmations for KLOW and three for GLOW.
- GHK-Cu content can additionally be checked by elemental analysis for copper, which is a meaningful identity test only because the metal is part of that compound.
- The visible colour is informative: the copper complex is blue, so both blends carry a colour cast that a blend without it would not.
References
Primary literature for the compounds discussed above. Links open the record on PubMed.
- The potential of GHK as an anti-aging peptide Pickart L, et al. Aging Pathobiol Ther. 2022. PMID 35083444 → · summary
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data Pickart L, et al. Int J Mol Sci. 2018. PMID 29986520 → · summary
- Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis Xiao B, et al. Mol Ther. 2017. PMID 28456380 → · summary
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation Dalmasso G, et al. Gastroenterology. 2008. PMID 18061177 → · summary
Primary sources
- The potential of GHK as an anti-aging peptideAging Pathobiol Ther · 2022
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene DataInt J Mol Sci · 2018
- Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative ColitisMol Ther · 2017 · animal study
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammationGastroenterology · 2008 · animal study
Frequently asked questions
- What is the difference between KLOW and GLOW?
- KPV. KLOW is a four-component blend of GHK-Cu, BPC-157, TB-500 and KPV at 80 mg total; GLOW is the same core without KPV at 70 mg total across three components.
- What do the names KLOW and GLOW mean?
- They are acronyms of their components rather than descriptions. Like all blend names they identify a product rather than a substance, and neither has a CAS number or molecular weight of its own.
- How should a blend COA report purity?
- Per component. A single area-percent figure for a mixture does not describe any individual peptide in it. A KLOW COA should carry four mass-spectrometry confirmations and GLOW three.
Compounds discussed in this guide
More on identification
- GHK-Cu vs KPV: metal complex or plain peptideTwo small tissue-research peptides with a fundamental difference: one carries a copper ion as part of the compound, the other does not. That changes storage, colour and COA reading.
- GLOW 70 — what is actually in the vialwhat GLOW 70 containsGLOW 70 is 70 mg across three compounds: 50 mg GHK-Cu, 10 mg TB-500, 10 mg BPC-157. The mass split defines the vial — not the name, which no standards body controls.
- KLOW 80 — what is actually in the vialKLOW 80 is 80 mg across four compounds: GHK-Cu, BPC-157, TB-500 and KPV. What the fourth component adds, and why a blend name is not a formulation.
All products discussed in this guide are supplied by Bench Grade Peptides for laboratory research use only. Not for human or veterinary use.